Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Global Market Opportunities And Strategies To 2032
Including: 1)By Type: Contract Manufacturing Services; Contract Research Servicesa) By CMO Service: Active Pharmaceutical Ingredients (API) Manufacturing; Finished Dosage Formulation (FDF) Development And Manufacturing; Secondary Packagingb) By CRO Service: Preclinical; Phase I; Phase II; Phase III; Phase IV2)By End User: Big Pharmaceutical Companies; Generic Pharmaceutical Companies; Small And Medium-Sized Pharmaceutical CompaniesCovering: Lonza Group; Catalent Inc.; WuXi AppTec Inc.; Pfizer Inc.; Recipharm AB
Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global pharmaceutical contract development and manufacturing organization (CDMO) market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Description:
Where is the largest and fastest growing market for pharmaceutical contract development and manufacturing organization (CDMO)? How does the market relate to the overall economy, demography, and other similar markets? What forces will shape the market going forward? The pharmaceutical contract development and manufacturing organization (CDMO) market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical contract development and manufacturing organization (CDMO) market; and compares it with other markets.
The report covers the following chapters.
- Introduction And Market Characteristics
Brief introduction to the segmentations covered in the market, definitions and explanations about the pharmaceutical contract development and manufacturing organization (CDMO) market.
Highlights the major trends shaping the global pharmaceutical contract development and manufacturing organization (CDMO) market. This section also highlights likely future developments in the market.
The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on the global and regional markets, providing strategic insights for businesses in the pharmaceutical contract development and manufacturing organization (CDMO) market.
- Global Market Size And Growth
Global historic (2017-2022) and forecast (2022-2027, 2032F) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis
Historic (2017-2022) and forecast (2022-2027, 2032F) market values and growth and market share comparison by region and country.
Contains the market values (2017-2022) (2022-2027, 2032F) and analysis for each segment by type, by CMO service, by CRO service and by end user in the market.
- Regional Market Size And Growth
Regional market size (2022), historic (2017-2022) and forecast (2022-2027, 2032F) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Key Mergers And Acquisitions
Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
- Market Opportunities And Strategies
Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations
This section Includes recommendations for pharmaceutical contract development and manufacturing organization (CDMO) providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope
Markets Covered:
1)By Type: Contract Manufacturing Services; Contract Research Services
a) By CMO Service: Active Pharmaceutical Ingredients (API) Manufacturing; Finished Dosage Formulation (FDF) Development And Manufacturing; Secondary Packaging
b) By CRO Service: Preclinical; Phase I; Phase II; Phase III; Phase IV
2)By End User: Big Pharmaceutical Companies; Generic Pharmaceutical Companies; Small And Medium-Sized Pharmaceutical Companies
Companies Mentioned: Lonza Group; Catalent Inc; WuXi AppTec Inc.; Pfizer Inc; Recipharm AB
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; Argentina; Chile; Colombia; Peru; France; Germany; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; pharmaceutical contract development and manufacturing organization (CDMO) indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.